196 related articles for article (PubMed ID: 17148581)
1. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia.
Martin V; Agirre X; Jiménez-Velasco A; José-Eneriz ES; Cordeu L; Gárate L; Vilas-Zornoza A; Castillejo JA; Heiniger A; Prósper F; Torres A; Roman-Gomez J
Cancer Sci; 2008 Sep; 99(9):1865-8. PubMed ID: 18549404
[TBL] [Abstract][Full Text] [Related]
4. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
6. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
Chim CS; Pang R; Liang R
J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Wnt signaling pathway in urological cancer.
Costa VL; Henrique R; Ribeiro FR; Carvalho JR; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
Epigenetics; 2010 May; 5(4):343-51. PubMed ID: 20421722
[TBL] [Abstract][Full Text] [Related]
11. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
[TBL] [Abstract][Full Text] [Related]
12. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
13. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
15. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V
Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816
[TBL] [Abstract][Full Text] [Related]
17. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
[TBL] [Abstract][Full Text] [Related]
19. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
Khan NI; Bradstock KF; Bendall LJ
Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
